acacetin [Ligand Id: 13776] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL243664 (NSC-76061) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| CYP1B1/Cytochrome P450 1B1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4878] [GtoPdb: 1320] [UniProtKB: Q16678] | ||||||||
| GtoPdb | - | - | 8.15 | pKi | 7 | nM | Ki | Eur J Med Chem (2017) 135: 296-306 [PMID:28458135] |
| ChEMBL | Inhibition of CYP1B1 (unknown origin) | B | 8.15 | pKi | 7 | nM | Ki | Eur J Med Chem (2017) 135: 296-306 [PMID:28458135] |
| ChEMBL | Inhibition of human CYP1B1 expressed in Escherichia coli DH5alpha coexpressing human NADPH P450 reductase using 7-ethoxyresorufin as substrate in presence of NADP+ by spectrofluorometeric analysis | B | 7.85 | pIC50 | 14 | nM | IC50 | Eur J Med Chem (2017) 135: 296-306 [PMID:28458135] |
| ChEMBL | Inhibition of human CYP1B1 by EROD assay | B | 7.92 | pIC50 | 12 | nM | IC50 | Bioorg Med Chem (2010) 18: 6310-6315 [PMID:20696580] |
| Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
| ChEMBL | Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method | B | 4.49 | pIC50 | 32400 | nM | IC50 | US-8461198-B2. Use of acacetin and related compounds as potassium channel inhibitors (2013) |
| Inositol hexakisphosphate kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523488] [UniProtKB: Q9UHH9] | ||||||||
| ChEMBL | Inhibition of human IP6K2 using insP6 as substrate preincubated for 15 mins followed by substrate and measured after 30 mins by TR-FRET assay | B | 5.24 | pIC50 | 5700 | nM | IC50 | J Med Chem (2019) 62: 1443-1454 [PMID:30624931] |
| Inositol polyphosphate multikinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523401] [UniProtKB: Q8NFU5] | ||||||||
| ChEMBL | Inhibition of human IPMK using insP3 as substrate preincubated for 15 mins followed by substrate and measured after 30 mins by TR-FRET assay | B | 4.52 | pIC50 | >30000 | nM | IC50 | J Med Chem (2019) 62: 1443-1454 [PMID:30624931] |
| Monoamine oxidase A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1951] [GtoPdb: 2489] [UniProtKB: P21397] | ||||||||
| ChEMBL | Competitive inhibition of recombinant human MAO-A assessed as reduction in 4-hydroxyquinoline formation using varying levels of kynuramine as substrate after 20 mins by Lineweaver-Burk plot analysis | B | 7.23 | pKi | 59.2 | nM | Ki | J Nat Prod (2016) 79: 2538-2544 [PMID:27754693] |
| GtoPdb | - | - | 7.23 | pKi | 59.2 | nM | Ki | J Nat Prod (2016) 79: 2538-2544 [PMID:27754693] |
| ChEMBL | Inhibition of recombinant human MAO-A using kynuramine as substrate incubated for 20 mins by spectrophotometric method | B | 6.72 | pIC50 | 190 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2403-2407 [PMID:29925480] |
| ChEMBL | Inhibition of human recombinant MAOA using kynuramine as substrate preincubated for 30 mins followed by substrate addition | B | 6.72 | pIC50 | 190 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 584-588 [PMID:29395970] |
| ChEMBL | Inhibition of recombinant human MAO-A assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate after 20 mins by fluorometric assay | B | 6.92 | pIC50 | 121 | nM | IC50 | J Nat Prod (2016) 79: 2538-2544 [PMID:27754693] |
| Monoamine oxidase B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2039] [GtoPdb: 2490] [UniProtKB: P27338] | ||||||||
| ChEMBL | Competitive inhibition of recombinant human MAO-B assessed as reduction in 4-hydroxyquinoline formation using varying levels of kynuramine as substrate after 20 mins by Lineweaver-Burk plot analysis | B | 7.31 | pKi | 49 | nM | Ki | J Nat Prod (2016) 79: 2538-2544 [PMID:27754693] |
| GtoPdb | - | - | 7.31 | pKi | 49 | nM | Ki | J Nat Prod (2016) 79: 2538-2544 [PMID:27754693] |
| ChEMBL | Inhibition of recombinant human MAO-B assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate after 20 mins by fluorometric assay | B | 7.31 | pIC50 | 49 | nM | IC50 | J Nat Prod (2016) 79: 2538-2544 [PMID:27754693] |
| Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
| ChEMBL | Antiplasmodial activity against synchronized ring stage Plasmodium falciparum 3D7 infected in human erythrocytes assessed as inhibition of parasite proliferation preincubated for 48 hrs followed by [3H]-hypoxanthine incorporation and measured after 24 hrs by microbeta liquid scintillation counter analysis | F | 4.4 | pIC50 | <40000 | nM | IC50 | J Nat Prod (2023) 86: 2661-2671 [PMID:37972998] |
| TRPV3/Transient receptor potential cation channel subfamily V member 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5522] [GtoPdb: 509] [UniProtKB: Q8NET8] | ||||||||
| ChEMBL | Antagonist activity at human TRPV3 channel expressed in HEK293T cells assessed as inhibition of 2-APB induced channel current by whole cell patch clamp recordings | B | 6.21 | pIC50 | 620 | nM | IC50 | Bioorg Med Chem Lett (2024) 98: 129577-129577 [PMID:38065293] |
| fms related receptor tyrosine kinase 3/Tyrosine-protein kinase receptor FLT3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1974] [GtoPdb: 1807] [UniProtKB: P36888] | ||||||||
| ChEMBL | Inhibition of recombinant His-tagged human FLT3 D835Y mutant (564 to 958 residues) expressed in baculovirus expression system using tyr 02 as substrate incubated for 1 hr by Z'-LYTE assay | B | 6 | pIC50 | 1000 | nM | IC50 | J Nat Prod (2021) 84: 1-10 [PMID:33393294] |
| ChEMBL | Inhibition of recombinant His-tagged human FLT3 (564 to 958 residues) expressed in baculovirus expression system using tyr 02 as substrate incubated for 1 hr by Z'-LYTE assay | B | 6.06 | pIC50 | 880 | nM | IC50 | J Nat Prod (2021) 84: 1-10 [PMID:33393294] |
| ChEMBL | Inhibition of recombinant N-terminal GST/His6-tagged human FLT3 ITD mutant (571 to 993 residues) expressed in Sf9 insect cells incubated for 1 hr by LanthaScreen assay | B | 6.68 | pIC50 | 210 | nM | IC50 | J Nat Prod (2021) 84: 1-10 [PMID:33393294] |
| Kv7.1/Voltage-gated potassium channel, IKs; KCNQ1(Kv7.1)/KCNE1(MinK) in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2221347] [GtoPdb: 560] [UniProtKB: P15382, P51787] | ||||||||
| ChEMBL | Inhibition of human KCNQ1/KCNE1 expressed in HEK293 cells assessed as decrease in current amplitude at +40 mV by whole cell patch clamp method | B | 4.09 | pIC50 | 81400 | nM | IC50 | US-8461198-B2. Use of acacetin and related compounds as potassium channel inhibitors (2013) |
| Kv1.5/Voltage-gated potassium channel subunit Kv1.5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4306] [GtoPdb: 542] [UniProtKB: P22460] | ||||||||
| ChEMBL | Inhibition of human Kv1.5 expressed in HEK293 cells by whole cell patch clamp method | B | 5.47 | pIC50 | 3400 | nM | IC50 | US-8461198-B2. Use of acacetin and related compounds as potassium channel inhibitors (2013) |
| ChEMBL | Inhibition of Kv1.5 in human atrial myocytes assessed as decrease in ultra rapidly activating delayed rectifier potassium current amplitude at 40 mV by whole cell patch clamp method | B | 5.49 | pIC50 | 3200 | nM | IC50 | US-8461198-B2. Use of acacetin and related compounds as potassium channel inhibitors (2013) |
| Kv4.3/Voltage-gated potassium channel subunit Kv4.3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1964] [GtoPdb: 554] [UniProtKB: Q9UK17] | ||||||||
| ChEMBL | Inhibition of Kv4.3 in human atrial myocytes assessed as decrease in transient outward potassium current amplitude by whole cell patch clamp method | B | 5.03 | pIC50 | 9300 | nM | IC50 | US-8461198-B2. Use of acacetin and related compounds as potassium channel inhibitors (2013) |
| Xanthine dehydrogenase in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3649] [UniProtKB: P80457] | ||||||||
| ChEMBL | Inhibition of cow milk xanthine oxidase | B | 4.85 | pIC50 | 14100 | nM | IC50 | J Nat Prod (1988) 51: 345-348 [PMID:3379415] |
| CYP1A1 in Human [GtoPdb: 1318] [UniProtKB: P04798] | ||||||||
| GtoPdb | - | - | 7.35 | pKi | 45 | nM | Ki | Eur J Med Chem (2017) 135: 296-306 [PMID:28458135] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
